Cargando…
Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy
Systemic biomarkers of inflammation, including cytokines and chemokines, are potentially useful in the management of both HIV infection and non-AIDS-defining disorders. However, relatively little is known about the utility of measurement of circulating biomarkers of platelet activation as a strategy...
Autores principales: | Steel, Helen C., Venter, W. D. Francois, Theron, Annette J., Anderson, Ronald, Feldman, Charles, Arulappan, Natasha, Rossouw, Theresa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878378/ https://www.ncbi.nlm.nih.gov/pubmed/33584658 http://dx.doi.org/10.3389/fimmu.2020.594110 |
Ejemplares similares
-
Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets
por: Madzime, Morris, et al.
Publicado: (2021) -
The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
por: Aoui, Chaker, et al.
Publicado: (2014) -
Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
por: Steel, Helen C., et al.
Publicado: (2018) -
ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
por: Anderson, Ronald, et al.
Publicado: (2020) -
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2
por: Aloui, Chaker, et al.
Publicado: (2016)